secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0000064803-24-000028
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q2 adj EPS $1.83 vs $2.21 YoY; cuts FY2024 adj EPS guidance to $6.40-$6.65
--------------------------------------------------------------------------------

- Total revenues $91.2B, up 2.6% YoY; GAAP diluted EPS $1.41 vs $1.48, Adjusted EPS $1.83 vs $2.21.
- Operating income $3.045B vs $3.234B; adjusted operating income $3.744B vs $4.481B, driven by Health Care Benefits segment pressure.
- FY2024 GAAP EPS guidance lowered to $4.95-$5.20 from at least $5.64; cash flow from ops guided to ~$9B from at least $10.5B.
- Health Care Benefits segment faces continued utilization pressure and unfavorable Medicare Advantage star ratings impact.
- CEO announces leadership changes in Health Care Benefits segment; strong performance in Health Services and Pharmacy & Consumer Wellness.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000028/0000064803-24-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000028/cvs-20240807.htm
  HTML page:      https://secwatch.observer/filing/0000064803-24-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer